Delivery Order SPE2DB22D3501-SPE2DB24FTL53
Award Date 11/7/23
Potential Completion Date 11/8/23
Potential Value $3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,918.82 fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of February 19, 2025 and does not involve any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award, valued at $2,841.65, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order for the supply of Entecavir 0.5 mg tablets, a generic medication used to treat chronic hepatitis B. The contract has an ultimate completion date of November 15, 2024 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award, valued at $6,501.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The award is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,108.23, is for the delivery of Entecavir 0.5 mg tablets and is a firm fixed-price delivery order. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, valued at $6,714.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. This is a Firm Fixed Price Delivery Order contract with a period of performance ending on May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several significant Indefinite Delivery...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,426.40 firm fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets. The contract has a completion date of May 19, 2023 and was awarded on May 18, 2023. No set-aside designations were indicated, suggesting open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Entecavir 0.5 mg tablets. The $2,211.77 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
- This federal contract award, valued at $5,586.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Entecavir 0.5 mg tablets, a pharmaceutical product used to treat hepatitis B. The award is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026....
- This federal contract award, valued at $3,091.35, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of October 29, 2024. This contract award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
- This federal contract award is a delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,433.10, is for the delivery of Entecavir 0.5 mg tablets. The contract is a firm fixed-price delivery order with a completion date of July 26, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite...